chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4 days after second dose patient has noted a feeling of heaviness and unsteadiness when walking.  He also feels sweaty in the morning
Hugh knot the size of her hand at injection site; Feeling hot/feverish at injection site; Redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (Hugh knot the size of her hand at injection site), VACCINATION SITE WARMTH (Feeling hot/feverish at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 058H21A, 002C21A and 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced VACCINATION SITE NODULE (Hugh knot the size of her hand at injection site), VACCINATION SITE WARMTH (Feeling hot/feverish at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, VACCINATION SITE NODULE (Hugh knot the size of her hand at injection site), VACCINATION SITE WARMTH (Feeling hot/feverish at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided. No treatment medication was provided.
Received vaccine at 9:00am, 9:15am light headache 10:30am felt light headed when walking.  12:00pm headache slightly stronger and discomfort in knees. 4:00pm joint aches specially in the knees, ankles and finger joints.  6:00pm tingling sensation on cheeks and headache persist.  Walking uncomfortably because of joint aches.
This spontaneous report has been received from a nurse referring to multiple unspecified patients. The patients' medical history, concurrent condition and concomitant therapy were not reported. On multiple unspecified dates, the multiple unspecified patients received doses of improperly stored PEDVAXHIB) (lot#N000237, expiration date 25-OCT-2019) (dose, frequency and route were not reported). The vaccine was exposed to temperature excursion of 47 degree Fahrenheit (F) to 77 F for 3 hours and 47 minutes and the data logger was involved. There was no previous temperature excursion. No adverse effects reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1708USA010267.
PATIENT HAS NECK AND SHOULDER PAIN ON LEFT SIDE WHERE VACCINE WAS ADMINISTERED; TAKES OTC ANALGESIC TO ASSIST WITH PAIN; PAIN IS IMPROVING DAILY BUT STILL THERE
Patient called on 5/31/07 in pm to report that after receiving MMR on 5/15/07 he began having problems with "intense jaw pain" and "pain near his ears." States that the pain started about 48 hrs. after receiving the vaccine. He reported no other symptoms, but stated that the pain has remained persistent and has not seemed to improve. I called our Chief Medical Officer, who didn't feel the problem was vaccine-related, but suggested that I file a VAERS report. Patient stated that he had not yet sought medical treatment. I advised him to contact his primary care physician about pain.
Difficulty breathing after the Moderna shot; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing after the Moderna shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Difficulty breathing after the Moderna shot). At the time of the report, DYSPNOEA (Difficulty breathing after the Moderna shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history  and relevant concomitant medications weren't reported Treatment information was not provided  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Vaccinated: 7:50PM Reaction: 7:50PM Pt with syncope fell and hit floor after vaccination; hit head, mid posterior nodule ~1.0-1.5cm. Pt with known vasovagal episodes usually in response to blood. Vitals: 102/46, 59, 12, O2 100% -> @7:58: 103/55, 84, 14, O2 100% -> 98/50, 102, 14, O2 100% Patient was stable and released from vaccination site with recommendation to follow up with healthcare provider. Pt went to ED from clinic to rule out concussion. Per ED note, extremely low risk for significant intracranial traumatic injury and would not benefit from head imaging at this time and syncope most consistent with vasovagal syncope.
Patient honked horn 10 minutes after receiving  vaccine. C/o numbness in left side of face and in left hand. No SOB. BP 110/64, HR WNL. 911 called at 3:54PM  and 25mg of liquid Benadaryl given orally. Red rash on patient's chest appeared at 3:46 PM, continued numbness. EMS arrived at 3:59PM. Report given and patient transferred to Hospital with normal vital signs and no SOB.
SORE ARM; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported. On an unspecified date, the subject experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.
soreness in the leftcalf; slight fever; occasional pressure inthe head; muscle twitches in theleft calf; strange tinglingsensations in the face; numbness spread across the left side of the body. Through the arm, shoulder, neck, face and down the leg; minor swelling in the throat; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Jul2021 at 17:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medication within two weeks of COVID-19 vaccine. On 27Jul2021 at 17:45, the patient experienced minor swelling in her throat but nothing alarming. On the same day at 18:00, the patient experienced strange tingling sensations in face, and after that a numbness spread across her left side of the body, Through her arm, shoulder, neck, face and down her leg. On the same day at 18:15, the patient experienced soreness in her left calf. Even her tongue was divided in two sides, numbness was slight but feeling sense was different on one each side. This had now persisted for 72 hours, and she had a slight fever, she experienced occasional pressure in her head and muscle twitches in her left calf. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events minor swelling in her throat, strange tingling sensations in face, and after that a numbness spread across her left side of the body, through her arm, shoulder, neck, face and down her leg, soreness in her left calf. Even her tongue was divided in two sides, numbness was slight but feeling sense was different on one each side, a slight fever, occasional pressure in her head and muscle twitches in her left calf was not recovered at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up
This spontaneous report as received from a medical assistant refers to a 15 year old patient of unspecified gender. On 13-MAR-2017, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # L009213 exp date 17-MAR-2017) (dose and route not reported). The temperature of excursion was 47 °F to 77 °F with a highest temperature of 55.1 °F for 15 minutes. There was no previous temperature excursion. A data logger issue was reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1703USA006936:
This spontaneous report as received from a physician via company representative refers to a patient of unknown age and unknown gender. Pertinent medical history, drug reactions or allergies were not provided. The reporter stated that the patient received GARDASIL outside the recommended dosing schedule. The patient received GARDASIL dose 1 on 04-AUG-2011, dose 2 on 01-AUG-2012 and dose 3 on 28-AUG-2014 (dosage, route, anatomical location, lot number and expiration date were unspecified). No adverse effects reported. No concomitant therapies were reported. The outcome of the events was unknown. Additional information is not expected because the reporter refused additional contact.
Fever 105ax on 7-31-08. gave tylenol with relief. fever up to 105 after 4hrs of taking tylenol.
patient was given YF-vax today but the diluent was expired with no adverse event; Initial information received on 25-Feb-2022 regarding an unsolicited valid  non-serious case received from a pharmacist.  This case involves an patient of unknown demographics who was given yf-vax today but the diluent was expired with no adverse event while receiving Yellow Fever Vaccine- US [YF-VAX].   The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On 25-Feb-2022, the patient received a  dose of suspect YF-VAX (strength, dose, route, administration site: unknown, Lot Number: UJ372AA, Expiration Date: 22-Jul-2022) for immunization. It was reported that Diluent of the YF-VAX had expired (Lot Number: U6428AA, Expiration Date: 09-Sep-2021).  On 25-Feb-2022 the patient was given YF-VAX  but it was reported that the diluent was expired with no adverse event (expired product administered) (Latency: same day).  Action taken was not applicable.  Outcome was Unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient mistakenly received the Pfizer pediatric Covid 19 vaccine and pediatric dose of 0.2ml; the patient is 12 years old and qualifies for the Pfizer adult Covid 19 vaccine and adult dose of 0.3ml  Error was caught while patient and patient's father were on site; patient and father were notified of the error, educated on the difference in Pfizer pediatric doses versus Pfizer adult doses, and notified that at the patient's second dose date the patient will receive the adult dose since she is 12 years old.
Hives appeared to neck  upper chest bilateral arms    Benadryl given orally (25mg)      Within 30 minutes Hives decreased
This spontaneous report was received from a nurse, refers to an unknown amount of patients of unknown age and gender. Pertinent medical history, drug reactions/allergies and concomitant medications were not reported. Nurse reported that improperly stored PROQUAD, lot # M007962, expiry date 15-AUG-2017, vaccines were administered to patients on unspecified dates after temperature excursion (temperature: 19.6 F, time range 1 hour and 30 minutes) on 13-JUL-2016. No adverse effects reported. The outcome of the events was unknown. No product quality complaint (PQC) was involved. This is one of three reports received from the same reporter. Additional information has been requested.
I was vaccinated/Suspected Vaccination Failure; Mild case of shingles; Bad pain; Fatigue; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: I was vaccinated/Suspected Vaccination Failure) (serious criteria GSK medically significant), shingles (Verbatim: Mild case of shingles), pain (Verbatim: Bad pain) and fatigue (Verbatim: Fatigue). The outcome of the vaccination failure was unknown and the outcome of the shingles, pain and fatigue were recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain and fatigue to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, pain and fatigue to be related to Shingles vaccine.   Additional Information: GSK receipt date: 10-MAR-2023 The case was received from the patient via interactive digital media. The patient was vaccinated with Shingles vaccine and still got a mild case of shingles.  The patient had pretty bad pain for a week and a half and fatigue for another couple weeks then all gone.  The patient stated that compared to the stories here, the vaccine was effective, he/she could not imagined what it would be like unvaccinated. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
I started having symptoms on September 28. 2022 i was super tired with fatigue and I usually don't have trouble with my knees but my knees started to bother me and I could hardly walk and it worsen the morning and I called my Dr he couldn't figure out what was wrong and after a few days I started to feel better. I wasn't prescribed any medications my symptoms subsided naturally.
2 shot regimen was given to me Feb 25 and Mar 25, 2021.  No issues until I moved in June 2021 and got a new Cardiologist.  He called for an Echocardiogram and saw severe regurgitation of the mitral valve.  I had 3 MitraClips installed to no avail.  Am now looking at heart surgery to replace Mitral valve.  I have no idea if the Covid vaccines caused this but was advised by CDC Vsafe to file this report.
Approximately 2 months after my 4th dose vaccination I contracted COVID-19 and experienced the following symptoms: Headache, Fever, Runny nose, Scratchy throat, Loss of smell and taste and Fatigue. I did not take anything for treatment and just decided to speak to my Doctor. He prescribed me with over the counter medications and basically to just let my symptoms run its course. As of today 07/08/2022 my symptoms have been better but I still have a low grade fever and fatigue.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. Pertinent medical history, drug reactions or allergies were not reported. On an unknown date the patient was administered with an improperly stored dose of ROTATEQ oral solution, (strength, dose, dose number, lot number and expiration date were unspecified). No concomitant therapies were reported. No adverse events were reported. The outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
She does complain of some flu like symptoms yesterday but very mild, with mild joint pains and bodyaches Patient reports she awoke in her usual state of health at 0730. She complained about continued pain and irritation at the site of her Shingrix vaccine in her L deltoid which she received on 5/23, along with some flu-like symptoms.  Patient also complained of continued sinus pain for "months"..   On admission to the CCU, patient denies chest pain, SOB, fevers, chills, recent tick exposures, rashes, neck/jaw/arm pain, or vision changes. She does endorse a "sinus headache" and some mild nausea.  Patient does have a significant family history of multiple siblings (x8) with CAD, 2 of which have had pacemakers placed.  Briefly, the patient is a 65-year-old presenting by ambulance after multiple syncopal episodes and extreme fatigue this morning.  She was noted to be bradycardic.  Pre-hospital EKG shows occasional QRS complexes.  She was hypotensive, but arousable.  She received 2 doses of atropine and her heart rate increased from the 20s to 30s.  There is still unable to obtain a blood pressure, however.  They started transcutaneous pacing.  Her blood pressure is in the mid 80s upon arrival.  Her pacing does appear to capture intermittently.  She is awake and arousable when I 1st evaluate her.  Two EKGs were performed, transcutaneous pacer was held for these.  There is no evidence of acute ischemia.  Rhythm is undetermined, some sort of complete heart block.  I spoke with Cardiology.  He evaluated the patient as well.      She was in her usual state of health upon waking up at her usual time at 7 AM this morning and took her Carvedilol and collagen supplement with Coffee and was sitting in a recliner and then does not remember much. Her husband found her confused and pre syncopal and called 911. The patient was placed on a dopamine drip.  This did improve her blood pressure and her heart rate somewhat.  Multiple labs were obtained. No acute electrolyte abnormalities.  Creatinine is normal.   The patient will be taken to the cath lab for emergent pacemaker placement and possible coronary evaluation as well. The patient's husband was at bedside and kept apprised of the findings and plan.
Baby had regular 6 week wellness check-up and received all reccomended vaccinations for 6 week old baby.   Straight after vaccination baby went to sleep, he then woke up 1 hour after with a screaming cry as if something was terribly wrong,  he then started vomiting uncontrollably (like a water fountain) and was in and out of consciousness, very lethargic, breathing started to reduce drastically, baby was floppy. Baby was handed to paramedics and rushed to emergency.    After event of vaccine reaction, doctors encouraged to continue with vaccinations,  baby was continuously in and out of hospital, suffered from stomach problems/pain as a todler and would notice todler seeking anything cold, usually resulting to lying down on stomach  on the cold floor because stomach was always burning hot. He would vomit regularly, suffer from regular nose bleeds for no apparent reason, behavioural/anger issues were displayed, headaches, asthma, and dry skin.
On Saturday nurse received a phone call from clients mother stating that 1 hour after getting vaccine child developed a rash all over his body.  She brought him to the emergency room where they ruled out strep and they were not sure what the rash was from.  Mother brought the child into the walk in clinic the following day and Dr. states that the rash is not related to the vaccine and the rash is viral.  Representative at the state suggested to fill out VAERS because the reaction was so soon after vaccination.
Tightness  and pain in chest leading to hospitalization and diagnosis of heart attack at 3 am
Flu Shot was fine at first but overtime developed aching where vaccine was deposited inside arm to point of interfering with sleep. Also general arm weakness and sharper pain at vaccine site with use. Clinic visit ruled out infection. Tried RX 6-day decreasing course of methylprednisolone. With Rx applied heat. Symptoms decreased with meds and heat but still had some pain with use and general weakness into December. By end of Dec was symptom free.
jumpstart rheumatoid arthritis; couldn't move it for day and a half.; arm had horrible sores; had a temperature over 99.6; joint pain as having "extra stuff in it that wouldn't make it"; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RHEUMATOID ARTHRITIS (jumpstart rheumatoid arthritis) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history provided.).    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced RHEUMATOID ARTHRITIS (jumpstart rheumatoid arthritis) (seriousness criterion medically significant), JOINT STIFFNESS (couldn't move it for day and a half.), SKIN ULCER (arm had horrible sores), PYREXIA (had a temperature over 99.6) and ARTHRALGIA (joint pain as having "extra stuff in it that wouldn't make it"). On 30-Mar-2021, JOINT STIFFNESS (couldn't move it for day and a half.) was resolving. At the time of the report, RHEUMATOID ARTHRITIS (jumpstart rheumatoid arthritis), SKIN ULCER (arm had horrible sores) and ARTHRALGIA (joint pain as having "extra stuff in it that wouldn't make it") was resolving and PYREXIA (had a temperature over 99.6) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Mar-2021, Body temperature: 99.6 had a temperature over 99.6, which is warmer than usual for her.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication and Treatment was not reported. Symptoms are currently healing and are on the downside. Doctor is worried about potential reaction to second dose. Patient wants to know efficacy after one dose and if reaction is normal.  Ok for safety to contact.  Email Preferred.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Further information has been requested.